Obstetric anesthesia

Surgical wound infiltration with liposomal bupivacaine admixture as an adjunct to intrathecal morphine for post-caesarean analgesia: a randomised, double-blind controlled trial

Int J Obstet AnesthPublished randomised, double-blind controlled trial

Primary result · Cumulative opioid consumption (oral morphine milligram equivalents)Result — go to the resultHodges-Lehmann estimate −3.05 mg 95% CI −5.9 to −1.4

Authors' conclusion

In women undergoing scheduled caesarean delivery, wound infiltration with a liposomal bupivacaine-bupivacaine hydrochloride admixture significantly reduced postoperative opioid consumption and improved pain scores. It may be an effective opioid-sparing adjunct to intrathecal morphine.

Study context

Population
Patients undergoing elective caesarean delivery with intrathecal morphine (100 μg)patients randomised
Participants
188 patients
Comparison
Wound infiltration with liposomal bupivacaine plus bupivacaine hydrochloride vs saline placebo, as an adjunct to intrathecal morphine
Primary endpoint
Cumulative opioid consumption (oral morphine milligram equivalents)
Follow-up
48 h
Methodological detailsplacebo-controlled
  • Placebo-controlled

Primary result

As reported in the abstract

Hodges-Lehmann estimate

−3.05 mg

95% CI −5.9 to −1.4

P = 0.002

By group

TREATMENTvs PLACEBO
Hodges-Lehmann estimate −3.05 mg (95% CI −5.9 to −1.4); P = 0.002

Secondary outcomes

OutcomeRR for opioid-free status (95% CI)P value
Opioid-free status · 48 hFavoured treatment9.0 (2.1–37.8)P < 0.001

24-h opioid consumption

Favoured treatment, P < 0.001

Movement-evoked pain · 24 h

Favoured treatment, P < 0.001

Movement-evoked pain · 48 h

Favoured treatment, P < 0.001

Time to first analgesic request

Favoured treatment, P < 0.001

Original publication

Surgical wound infiltration with liposomal bupivacaine admixture as an adjunct to intrathecal morphine for post-caesarean analgesia: a randomised, double-blind controlled trial. Int J Obstet Anesth. Published 2 November 2026. doi:10.1016/j.ijoa.2026.105307

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.